EWA
TXMD icon

EverSource Wealth Advisors’s TherapeuticsMD TXMD Stock Holding History

EverSource Wealth Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 4387
2026
Q1 		$2 Hold
1
– – ﹤0.01% 4381
2025
Q4 		$2 Hold
1
– – ﹤0.01% 4265
2025
Q3 		$1 Hold
1
– – ﹤0.01% 4320
2025
Q2 		$1 Hold
1
– – ﹤0.01% 4247
2025
Q1 		$1 Hold
1
– – ﹤0.01% 4010
2024
Q4 		$1 Hold
1
– – ﹤0.01% 3747
2024
Q3 		$2 Hold
1
– – ﹤0.01% 3031
2024
Q2 		$2 Hold
1
– – ﹤0.01% 3057
2024
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 2892

Other funds holding TXMD

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
FA
Fedenia Advisers Madison, Wisconsin $421M AUM 96.46% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
SWIM
Smallwood Wealth Investment Management Red Bank, New Jersey $229M AUM 23.56% 1-Year Est. Return

EverSource Wealth Advisors's TXMD Position: Q2 2026 in Review

EverSource Wealth Advisors held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4387.

EverSource Wealth Advisors first reported a position in TXMD in Q1 2024 and has held it in 10 quarters since. 9 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

  • EverSource Wealth Advisors held 1 share of TherapeuticsMD worth $2 as of Q2 2026.
  • EverSource Wealth Advisors left its TherapeuticsMD share count unchanged in Q2 2026.
  • TherapeuticsMD made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4387 holding.
  • EverSource Wealth Advisors first reported a position in TherapeuticsMD in Q1 2024 and has held it in 10 quarters since.
  • 9 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.